RemeGen Co. Ltd. Class H (REGMF) Stock Forecast & Price Target
REGMF Analyst Ratings
Strong Buy
8Buy1Hold0Sell
Based on 9 analysts giving stock ratings to RemeGen Co. Ltd. Class H in the past 3 months
REGMF Stock 12 Month Forecast
Average Price Target
$15.10▲(81.80% Upside)Based on 9 Wall Street analysts offering 12 month price targets for RemeGen Co. Ltd. Class H in the last 3 months. The average price target is $15.10 with a high forecast of $18.45 and a low forecast of $12.49. The average price target represents a 81.80% change from the last price of $8.31.
Past 12 Months12 Month ForecastDec2025Sep2026
High$18.45
Average$15.10
Low$12.49
Highest Price TargetHighest$18.45Average Price Target$15.10Lowest Price TargetLowest$12.49
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | UBS | $16.89 | buy | 103.34%Upside | Reiterated | 10/29/26 | ||
| Unknown AnalystNot Ranked | CICC | $14.39 | buy | 73.29%Upside | Reiterated | 08/31/26 | ||
| Unknown AnalystNot Ranked | SPDB | $12.66 | buy | 52.39%Upside | Reiterated | 08/27/26 | ||
| Unknown AnalystNot Ranked | Citi | $13.38→$16.28 | buy | 95.97%Upside | Reiterated | 08/26/26 | ||
| Unknown AnalystNot Ranked | Bank of China | $14.53 | buy | 74.95%Upside | Reiterated | 08/26/26 | ||
| Unknown AnalystNot Ranked | Daiwa | $13.51→$13.76 | buy | 65.74%Upside | Reiterated | 08/25/26 | ||
| Matthew Yan | CLSA | $18.45 | buy | 122.21%Upside | Reiterated | 08/25/26 | ||
| Unknown AnalystNot Ranked | Morgan Stanley | $12.49 | hold | 50.39%Upside | Reiterated | 08/25/26 | ||
| Yang Huang | J.P. Morgan | $16.44 | buy | 97.96%Upside | Reiterated | 08/06/26 | ||
| Unknown AnalystNot Ranked | CMBC International | $16.03 | buy | 92.98%Upside | Reiterated | 07/31/26 | ||
| Unknown AnalystNot Ranked | Nomura | $11.40 | hold | 37.26%Upside | Reiterated | 07/24/26 | ||
| Unknown AnalystNot Ranked | Shenwan Hongyuan | $15.93 | buy | 91.83%Upside | Reiterated | 05/14/26 | ||
| Unknown AnalystNot Ranked | First Shanghai Securities | $17.49 | buy | 110.55%Upside | Reiterated | 05/12/26 | ||
| Unknown AnalystNot Ranked | BOCOM International Holdings Company | $17.33 | buy | 108.71%Upside | Reiterated | 03/31/26 | ||
| Unknown AnalystNot Ranked | Zhongtai Securities | $14.53 | buy | 74.95%Upside | Upgraded | 01/20/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Unknown AnalystNot Ranked | 10/29/26 | $16.89 | buy | 103.34%Upside | Reiterated | UBS | ||
| Unknown AnalystNot Ranked | 08/31/26 | $14.39 | buy | 73.29%Upside | Reiterated | CICC | ||
| Unknown AnalystNot Ranked | 08/27/26 | $12.66 | buy | 52.39%Upside | Reiterated | SPDB | ||
| Unknown AnalystNot Ranked | 08/26/26 | $13.38→$16.28 | buy | 95.97%Upside | Reiterated | Citi | ||
| Unknown AnalystNot Ranked | 08/26/26 | $14.53 | buy | 74.95%Upside | Reiterated | Bank of China | ||
| Unknown AnalystNot Ranked | 08/25/26 | $13.51→$13.76 | buy | 65.74%Upside | Reiterated | Daiwa | ||
| Matthew Yan | 08/25/26 | $18.45 | buy | 122.21%Upside | Reiterated | CLSA | ||
| Unknown AnalystNot Ranked | 08/25/26 | $12.49 | hold | 50.39%Upside | Reiterated | Morgan Stanley | ||
| Yang Huang | 08/06/26 | $16.44 | buy | 97.96%Upside | Reiterated | J.P. Morgan | ||
| Unknown AnalystNot Ranked | 07/31/26 | $16.03 | buy | 92.98%Upside | Reiterated | CMBC International | ||
| Unknown AnalystNot Ranked | 07/24/26 | $11.40 | hold | 37.26%Upside | Reiterated | Nomura | ||
| Unknown AnalystNot Ranked | 05/14/26 | $15.93 | buy | 91.83%Upside | Reiterated | Shenwan Hongyuan | ||
| Unknown AnalystNot Ranked | 05/12/26 | $17.49 | buy | 110.55%Upside | Reiterated | First Shanghai Securities | ||
| Unknown AnalystNot Ranked | 03/31/26 | $17.33 | buy | 108.71%Upside | Reiterated | BOCOM International Holdings Company | ||
| Unknown AnalystNot Ranked | 01/20/26 | $14.53 | buy | 74.95%Upside | Upgraded | Zhongtai Securities |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering RemeGen Co. Ltd. Class H
3 Months
Success Rate3/6 ratings generated profit
50%
Average Return
+0.10%
Copying Yang Huang's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +0.10% per trade.
1 Year
Success Rate2/6 ratings generated profit
33%
Average Return
+9.25%
Copying Yang Huang's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +9.25% per trade.
2 Years
Success Rate3/6 ratings generated profit
50%
Average Return
+70.20%
Copying Matthew Yan's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +70.20% per trade.
REGMF Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 7 | 6 | 6 |
| Buy | 4 | 2 | 5 | 5 | 5 |
| Hold | 1 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 7 | 7 | 14 | 13 | 12 |
In the current month, REGMF has received 11 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. REGMF average Analyst price target in the past 3 months is 15.10.
REGMF Financial Forecast
High$0.13
Consensus$0.13
Low$0.13
REGMF Earnings Forecast
Next quarter’s earnings estimate for REGMF is $0.13 with a range of $0.13 to $0.13. The previous quarter’s EPS was $0.16. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High$252M
Consensus$252M
Low$252M
REGMF Sales Forecast
Next quarter’s sales forecast for REGMF is $252.46M with a range of $252.46M to $252.46M. The previous quarter’s sales results were $134.98M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
REGMF Stock Forecast FAQ
What is REGMF’s average 12-month price target, according to analysts?
Based on analyst ratings, RemeGen Co. Ltd. Class H’s 12-month average price target is $15.10.
What is REGMF’s upside potential, based on the analysts’ average price target?
RemeGen Co. Ltd. Class H has 81.80% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is REGMF a Buy, Sell or Hold?
RemeGen Co. Ltd. Class H has a consensus rating of Strong Buy which is based on 8 buy ratings, 1 hold ratings and 0 sell ratings.
What is RemeGen Co. Ltd. Class H’s price target?
The average price target for RemeGen Co. Ltd. Class H is $15.10. This is based on 9 12-month price targets, issued in the past 3 months. The highest analyst price target is $18.45, the lowest forecast is $12.49. The average price target represents a 81.80% increase from the current price of $8.305.
What do analysts say about RemeGen Co. Ltd. Class H?
RemeGen Co. Ltd. Class H’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Street analysts.
How can I buy shares of REGMF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
